1. Home
  2. STVN vs FOUR Comparison

STVN vs FOUR Comparison

Compare STVN & FOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • FOUR
  • Stock Information
  • Founded
  • STVN 1949
  • FOUR 1999
  • Country
  • STVN Italy
  • FOUR United States
  • Employees
  • STVN N/A
  • FOUR N/A
  • Industry
  • STVN Containers/Packaging
  • FOUR Business Services
  • Sector
  • STVN Consumer Discretionary
  • FOUR Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • FOUR Nasdaq
  • Market Cap
  • STVN 6.2B
  • FOUR 6.9B
  • IPO Year
  • STVN 2021
  • FOUR 2020
  • Fundamental
  • Price
  • STVN $22.96
  • FOUR $90.45
  • Analyst Decision
  • STVN Buy
  • FOUR Buy
  • Analyst Count
  • STVN 4
  • FOUR 20
  • Target Price
  • STVN $25.13
  • FOUR $113.28
  • AVG Volume (30 Days)
  • STVN 341.4K
  • FOUR 2.5M
  • Earning Date
  • STVN 08-05-2025
  • FOUR 08-05-2025
  • Dividend Yield
  • STVN 0.27%
  • FOUR N/A
  • EPS Growth
  • STVN 6.78
  • FOUR 55.45
  • EPS
  • STVN 0.57
  • FOUR 2.56
  • Revenue
  • STVN $1,344,798,591.00
  • FOUR $3,610,700,000.00
  • Revenue This Year
  • STVN $8.24
  • FOUR $28.69
  • Revenue Next Year
  • STVN $10.38
  • FOUR $24.06
  • P/E Ratio
  • STVN $40.05
  • FOUR $35.26
  • Revenue Growth
  • STVN 5.28
  • FOUR 23.86
  • 52 Week Low
  • STVN $17.12
  • FOUR $68.09
  • 52 Week High
  • STVN $28.00
  • FOUR $127.50
  • Technical
  • Relative Strength Index (RSI)
  • STVN 47.98
  • FOUR 45.43
  • Support Level
  • STVN $21.51
  • FOUR $88.93
  • Resistance Level
  • STVN $23.72
  • FOUR $92.47
  • Average True Range (ATR)
  • STVN 0.84
  • FOUR 2.49
  • MACD
  • STVN 0.09
  • FOUR 0.55
  • Stochastic Oscillator
  • STVN 65.77
  • FOUR 70.38

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.

Share on Social Networks: